{
    "clinical_study": {
        "@rank": "41797", 
        "arm_group": [
            {
                "arm_group_label": "Group 1", 
                "arm_group_type": "Experimental", 
                "description": "Group 1 will receive IV acetaminophen 1000mg plus 2 oral capsules \"sugar pills\" 1 hour prior to surgical incision and 4 hours after initial dose, for a total of two doses of acetaminophen totaling or equaling 2000mg"
            }, 
            {
                "arm_group_label": "Group 2", 
                "arm_group_type": "Experimental", 
                "description": "Group 2 will receive an IV \"salt water\" infusion plus 2 capsules of oral acetaminophen 1 hour prior to surgical incision and 4 hours after initial dose, for a total of two doses totaling or equaling 2000mg."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to learn whether perioperative IV (intravenous) administration\n      of acetaminophen (commonly referred to as Tylenol) shows any different clinical outcomes\n      over the oral (by mouth) administration of acetaminophen for a patient having a laparoscopic\n      cholecystectomy. If improved pain scores occur with the administration of IV acetaminophen,\n      it may result in fewer requests for pain-related intervention such as other oral pain\n      medications."
        }, 
        "brief_title": "A Prospective, Randomized, Double Blind, Comparative-effectiveness Study Comparing Perioperative Administration of Oral Versus Intravenous Acetaminophen for Laparoscopic Cholecystectomy", 
        "condition": "Laparoscopic Cholecystectomy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male and female patients ASA I - III (A system used by anesthesiologists to stratify\n             severity of patients' underlying disease and potential for suffering complications\n             from general anesthesia ), 18 years of age and older\n\n          -  Patient must be scheduled for laparoscopic cholecystectomy\n\n        Exclusion Criteria:\n\n          -  Chronic pain syndromes (pain symptoms lasting greater than 3 months), previous\n             abdominal surgery\n\n          -  Chronic home narcotic use (patient-reported narcotic use for greater than 3 months)\n\n          -  Liver disease (AST or ALT greater than 3 times upper limit of normal), on labs\n             closest to surgical date or within 6 months prior to surgery\n\n          -  Severe renal disease (creatinine clearance less than 30 mL/min), on labs closest to\n             surgical date or within 6 months prior to surgery\n\n          -  Open or emergency surgery (non-scheduled surgery, surgery that must be performed\n             within 6 hours for this particular surgery)\n\n          -  Prior NSAIDS(Non-Steroid Anti-inflammatory Drugs) including COX-2 agents use within\n             the last 24 hours\n\n          -  Use of intraoperative NSAIDs\n\n          -  Contraindication to study drug (including allergic reaction or hypersensitivity to\n             acetaminophen or any of its components;\n\n          -  On a medication with known interactions with acetaminophen\n\n          -  On chronic oral acetaminophen, greater than 6 months on a daily basis at a dose\n             greater than 3000mg/day\n\n          -  Pregnancy\n\n          -  Current or past alcohol abuse (within the past 2 years)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "220", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01823224", 
            "org_study_id": "380250"
        }, 
        "intervention": [
            {
                "arm_group_label": "Group 2", 
                "intervention_name": "2 capsules Oral Tylenol 2000 mg and IV \"salt water\"", 
                "intervention_type": "Drug", 
                "other_name": "Acetaminophen is comercially referred to as Tylenol."
            }, 
            {
                "arm_group_label": "Group 1", 
                "intervention_name": "IV tylenol 1000mg and 2 oral capsule \"sugar pills\"", 
                "intervention_type": "Drug", 
                "other_name": "Acetaminophen is comercially referred to as Tylenol."
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Acetaminophen"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 6, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Fort Bragg", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "28310"
                }, 
                "name": "Womack Army Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Randomized, Double Blind, Comparative-effectiveness Study Comparing Perioperative Administration of Oral Versus Intravenous Acetaminophen for Laparoscopic Cholecystectomy", 
        "overall_contact": {
            "email": "amccoart@dvpmi.org", 
            "last_name": "Amy McCoart", 
            "phone": "910-907-6239"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Pain after treatment with IV versus oral tylenol will be assessed via pain scores", 
            "measure": "Pain", 
            "safety_issue": "No", 
            "time_frame": "24 hours after discharge"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01823224"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Pain diary will be filled out every 6 hours for 24 hours after discharge in which the following will be recorded:\nOpioid consumption from first waking to T4\nTotal opioid consumption from T0 to T4\nTotal opioid consumption from time of first waking to T24\nTime to first use of rescue medication", 
            "measure": "Opioid Use", 
            "safety_issue": "No", 
            "time_frame": "every 6 hours for 24 hours"
        }, 
        "source": "Defense and Veterans Center for Integrative Pain Management", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Defense and Veterans Center for Integrative Pain Management", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}